Petmed Express Inc (PETS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While insider buying is a positive signal, the company's financial performance shows significant revenue decline and negative earnings. Additionally, technical indicators and options data do not suggest a strong upward momentum. The lack of recent news or significant catalysts further supports a cautious approach.
The MACD is slightly positive but contracting, RSI is neutral at 29.426, and moving averages are converging, indicating no clear trend. The stock is trading near its S1 support level of 2.227, with resistance at 2.421. Overall, technical indicators suggest a neutral to slightly bearish sentiment.

Insiders are buying, with a 174.01% increase in buying activity over the last month, which could indicate confidence in the company's future.
Revenue dropped by 21.75% YoY in Q3 2026, and gross margin declined by 19.33% YoY. The stock has a 50% chance of declining further in the short term, with a potential -17.69% drop in the next month.
In Q3 2026, revenue declined to $40.66M (-21.75% YoY), but net income improved to -$10.55M (+1392.64% YoY). EPS also improved to -0.5 (+1566.67% YoY). However, the gross margin dropped to 22.58% (-19.33% YoY), indicating operational challenges.
No recent analyst ratings or price target changes are available for PETS.
